Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

NCT06408181 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT06408181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06408181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Lead sponsor
University of Pennsylvania
Phase
Phase 3
Overall status
Recruiting
Start date
June 12, 2024
Completion date
June 30, 2029
Enrollment
1,150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pre-eclampsia, pregnancy loss